Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors

被引:17
|
作者
Pinchuk, Boris [1 ]
Horbert, Rebecca [1 ]
Doebber, Alexander [1 ]
Kuhl, Lydia [1 ]
Peifer, Christian [1 ]
机构
[1] Univ Kiel, Inst Pharm, Gutenbergstr 76, D-24118 Kiel, Germany
来源
MOLECULES | 2016年 / 21卷 / 05期
关键词
photoactivatable prodrugs; caging; receptor tyrosine kinase; kinase inhibitors; VEGFR-2; 3,4-diarylmaleimides; photoremovable protecting group (PPG); ENDOTHELIAL-GROWTH-FACTOR; PHOTOREMOVABLE PROTECTING GROUPS; TARGETED THERAPY; ANGIOGENESIS; BIOLOGY; CHEMISTRY; RADIATION; DESIGN; ROLES;
D O I
10.3390/molecules21050570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we report on the design, synthesis, photokinetic properties and in vitro evaluation of photoactivatable caged prodrugs for the receptor tyrosine kinase VEGFR-2. Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the caged prodrugs 4 and 5. As expected, enzymatic and cellular proliferation assays showed dramatically diminished efficacy of caged prodrugs in vitro. Upon ultraviolet (UV) irradiation of the prodrugs original inhibitory activity was completely restored and even distinctly reinforced, as was the case for the prodrug 4. The presented results are a further evidence for caging technique being an interesting approach in the protein kinase field. It could enable spatial and temporal control for the inhibition of VEGFR-2. The described photoactivatable prodrugs might be highly useful as biological probes for studying the VEGFR-2 signal transduction.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Novel VEGFR-2 kinase inhibitors for the treatment of cancer
    Boyer, SJ
    Burke, JM
    Brennan, CR
    Brini, W
    Collibee, W
    Dixon, JA
    Dumas, J
    Ehrgott, F
    Hatoum-Mokdad, H
    Hong, ZQ
    Kluender, HC
    Lee, W
    Ma, X
    Reeves, R
    Sibley, RN
    Turner, T
    Wong, W
    Zhang, YL
    Brink, C
    Carter, C
    Chang, Y
    Chien, DS
    Cortes, C
    Elting, J
    Jones, RM
    McHugh, M
    Natrillo, A
    Polony, B
    Vincent, P
    Wilkie, D
    Webb, D
    Zhu, GC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2505 - U2505
  • [2] Development of thienopyridines as VEGFR-2 kinase inhibitors.
    Munchhof, MJ
    Adams, MA
    Atherton, JA
    Beebe, JS
    Casavant, JC
    Cooper, BC
    Doty, JD
    Emerson, EE
    Foster, BF
    Gant, TG
    Garshasb, SG
    Goodwin, PG
    Harriman, SH
    Higdon, CH
    Hillerman, SH
    Interi, CI
    Jani, JJ
    Knauth, LK
    Marx, MM
    Natarajan, VN
    Noe, MN
    Rossi, AR
    Savage, DS
    Shaeffer, TS
    Smolarek, TS
    Snow, SS
    Sobolov, SS
    Soderstrom, ES
    Sun, JS
    Turncliff, RT
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U197 - U197
  • [3] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Liu, Ting
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Ding, Jian
    Xie, Hua
    Duan, Wenhu
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
  • [4] Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity
    Munchhof, MJ
    Beebe, JS
    Casavant, JM
    Cooper, BA
    Doty, JL
    Higdon, RC
    Hillerman, SM
    Soderstrom, CI
    Knauth, EA
    Marx, MA
    Rossi, AMK
    Sobolov, SB
    Sun, JM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 21 - 24
  • [5] Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
    Lee, Kyungik
    Jeong, Ki-Woong
    Lee, Yeonjoo
    Song, Ji Yeon
    Kim, Maeng Sup
    Lee, Gwan Sun
    Kim, Yangmee
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 5420 - 5427
  • [6] De novo Design of Indole Derivatives as VEGFR-2 Tyrosine Kinase Inhibitors
    Kang Congmin
    Zhao Xuhao
    Yu Yuqi
    Lu Yingtao
    [J]. CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2014, 35 (03): : 550 - 554
  • [7] Virtual Screening and Synthesis of New Chemical Scaffolds as VEGFR-2 Kinase Inhibitors
    Elsayed, M. S.
    El-Araby, M. E.
    Serya, R. T.
    Abouzid, K. A. M.
    [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 554 - 560
  • [8] Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach
    Sanphanya, Kingkan
    Wattanapitayakul, Suvara K.
    Phowichit, Suwadee
    Fokin, Valery V.
    Vajragupta, Opa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 2962 - 2967
  • [9] Design, synthesis and biological evaluation of biphenylurea derivatives as VEGFR-2 kinase inhibitors(Ⅱ)
    Guo-Rui Gao
    Meng-Yuan Li
    Yong-Cong Lv
    Su-Fen Cao
    Lin-Jiang Tong
    Li-Xin Wei
    Jian Ding
    Hua Xie
    Wen-Hu Duan
    [J]. Chinese Chemical Letters, 2016, 27 (02) : 200 - 204
  • [10] Development and strategies of VEGFR-2/KDR inhibitors
    Huang, Lingyi
    Huang, Zhengui
    Bai, Zhigiang
    Xie, Rui
    Sun, Liping
    Lin, Kejiang
    [J]. FUTURE MEDICINAL CHEMISTRY, 2012, 4 (14) : 1839 - 1852